These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 25291144)
21. The inhibiting effect of the Coptis chinensis polysaccharide on the type II diabetic mice. Cui L; Liu M; Chang X; Sun K Biomed Pharmacother; 2016 Jul; 81():111-119. PubMed ID: 27261584 [TBL] [Abstract][Full Text] [Related]
22. H1-antihistamines exacerbate high-fat diet-induced hepatic steatosis in wild-type but not in apolipoprotein E knockout mice. Raveendran VV; Kassel KM; Smith DD; Luyendyk JP; Williams KJ; Cherian R; Reed GA; Flynn CA; Csanaky IL; Lickteig AL; Pratt-Hyatt MJ; Klaassen CD; Dileepan KN Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G219-28. PubMed ID: 24852568 [TBL] [Abstract][Full Text] [Related]
23. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice. Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960 [TBL] [Abstract][Full Text] [Related]
24. Progressive erosion of β-cell function precedes the onset of hyperglycemia in the NOD mouse model of type 1 diabetes. Ize-Ludlow D; Lightfoot YL; Parker M; Xue S; Wasserfall C; Haller MJ; Schatz D; Becker DJ; Atkinson MA; Mathews CE Diabetes; 2011 Aug; 60(8):2086-91. PubMed ID: 21659497 [TBL] [Abstract][Full Text] [Related]
25. Amelioration of high fat diet-induced glucose intolerance by blockade of Smad4 in pancreatic beta-cells. Li HY; Oh YS; Lee YJ; Lee EK; Jung HS; Jun HS Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):221-6. PubMed ID: 25502579 [TBL] [Abstract][Full Text] [Related]
26. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models. Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Weisinger RS; Stanley TK; Begg DP; Weisinger HS; Spark KJ; Jois M Physiol Behav; 2009 Aug; 98(1-2):192-7. PubMed ID: 19465040 [TBL] [Abstract][Full Text] [Related]
28. Dose dependency of brain histamine H(1) receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin. Tashiro M; Kato M; Miyake M; Watanuki S; Funaki Y; Ishikawa Y; Iwata R; Yanai K Hum Psychopharmacol; 2009 Oct; 24(7):540-8. PubMed ID: 19697300 [TBL] [Abstract][Full Text] [Related]
29. Sulforaphane ameliorates glucose intolerance in obese mice via the upregulation of the insulin signaling pathway. Xu Y; Fu JF; Chen JH; Zhang ZW; Zou ZQ; Han LY; Hua QH; Zhao JS; Zhang XH; Shan YJ Food Funct; 2018 Sep; 9(9):4695-4701. PubMed ID: 30091431 [TBL] [Abstract][Full Text] [Related]
30. Loss of Toll-Like Receptor 4 Function Partially Protects against Peripheral and Cardiac Glucose Metabolic Derangements During a Long-Term High-Fat Diet. Jackson EE; Rendina-Ruedy E; Smith BJ; Lacombe VA PLoS One; 2015; 10(11):e0142077. PubMed ID: 26539824 [TBL] [Abstract][Full Text] [Related]
31. Extract of Ginkgo Biloba Ameliorates Streptozotocin-Induced Type 1 Diabetes Mellitus and High-Fat Diet-Induced Type 2 Diabetes Mellitus in Mice. Rhee KJ; Lee CG; Kim SW; Gim DH; Kim HC; Jung BD Int J Med Sci; 2015; 12(12):987-94. PubMed ID: 26664261 [TBL] [Abstract][Full Text] [Related]
32. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model. Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226 [TBL] [Abstract][Full Text] [Related]
33. GABA dramatically improves glucose tolerance in streptozotocin-induced diabetic rats fed with high-fat diet. Sohrabipour S; Sharifi MR; Talebi A; Sharifi M; Soltani N Eur J Pharmacol; 2018 May; 826():75-84. PubMed ID: 29391158 [TBL] [Abstract][Full Text] [Related]
34. Erythropoietin inhibits gluconeogenesis and inflammation in the liver and improves glucose intolerance in high-fat diet-fed mice. Meng R; Zhu D; Bi Y; Yang D; Wang Y PLoS One; 2013; 8(1):e53557. PubMed ID: 23326455 [TBL] [Abstract][Full Text] [Related]
35. MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice. Bhattacharjee A; Allister EM; Wheeler MB Can J Physiol Pharmacol; 2012 May; 90(5):663-8. PubMed ID: 22530993 [TBL] [Abstract][Full Text] [Related]
36. Lifelong obesity in a polygenic mouse model prevents age- and diet-induced glucose intolerance- obesity is no road to late-onset diabetes in mice. Renne U; Langhammer M; Brenmoehl J; Walz C; Zeissler A; Tuchscherer A; Piechotta M; Wiesner RJ; Bielohuby M; Hoeflich A PLoS One; 2013; 8(11):e79788. PubMed ID: 24236159 [TBL] [Abstract][Full Text] [Related]
37. Supplementation of SK1 from Platycodi radix ameliorates obesity and glucose intolerance in mice fed a high-fat diet. Kim JY; Moon KD; Seo KI; Park KW; Choi MS; Do GM; Jeong YK; Cho YS; Lee MK J Med Food; 2009 Jun; 12(3):629-36. PubMed ID: 19627213 [TBL] [Abstract][Full Text] [Related]
38. Administration of Tonsil-Derived Mesenchymal Stem Cells Improves Glucose Tolerance in High Fat Diet-Induced Diabetic Mice via Insulin-Like Growth Factor-Binding Protein 5-Mediated Endoplasmic Reticulum Stress Modulation. Lee Y; Shin SH; Cho KA; Kim YH; Woo SY; Kim HS; Jung SC; Jo I; Jun HS; Park WJ; Park JW; Ryu KH Cells; 2019 Apr; 8(4):. PubMed ID: 31018536 [TBL] [Abstract][Full Text] [Related]
39. Herring Milt Protein Hydrolysate Improves Insulin Resistance in High-Fat-Diet-Induced Obese Male C57BL/6J Mice. Wang Y; Gagnon J; Nair S; Sha S Mar Drugs; 2019 Aug; 17(8):. PubMed ID: 31382619 [TBL] [Abstract][Full Text] [Related]
40. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]